Cargando…

Evidence for Dual Activation of I(K(M)) and I(K(Ca)) Caused by QO-58 (5-(2,6-Dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1H-pyrazolol[1,5-a]pyrimidin-7-one)

QO-58 (5-(2,6-dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1H-pyrazolol[1,5-a]pyrimidin-7-one) has been regarded to be an activator of K(V)7 channels with analgesic properties. However, whether and how the presence of this compound can result in any modifications of other types of mem...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chao-Liang, Fu, Poyuan, Cho, Hsin-Yen, Chuang, Tzu-Hsien, Wu, Sheng-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266432/
https://www.ncbi.nlm.nih.gov/pubmed/35806047
http://dx.doi.org/10.3390/ijms23137042
_version_ 1784743472599662592
author Wu, Chao-Liang
Fu, Poyuan
Cho, Hsin-Yen
Chuang, Tzu-Hsien
Wu, Sheng-Nan
author_facet Wu, Chao-Liang
Fu, Poyuan
Cho, Hsin-Yen
Chuang, Tzu-Hsien
Wu, Sheng-Nan
author_sort Wu, Chao-Liang
collection PubMed
description QO-58 (5-(2,6-dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1H-pyrazolol[1,5-a]pyrimidin-7-one) has been regarded to be an activator of K(V)7 channels with analgesic properties. However, whether and how the presence of this compound can result in any modifications of other types of membrane ion channels in native cells are not thoroughly investigated. In this study, we investigated its perturbations on M-type K(+) current (I(K(M))), Ca(2+)-activated K(+) current (I(K(Ca))), large-conductance Ca(2+)-activated K(+) (BK(Ca)) channels, and erg-mediated K(+) current (I(K(erg))) identified from pituitary tumor (GH(3)) cells. Addition of QO-58 can increase the amplitude of I(K(M)) and I(K(Ca)) in a concentration-dependent fashion, with effective EC(50) of 3.1 and 4.2 μM, respectively. This compound could shift the activation curve of I(K(M)) toward a leftward direction with being void of changes in the gating charge. The strength in voltage-dependent hysteresis (V(hys)) of I(K(M)) evoked by upright triangular ramp pulse (V(ramp)) was enhanced by adding QO-58. The probabilities of M-type K(+) (K(M)) channels that will be open increased upon the exposure to QO-58, although no modification in single-channel conductance was seen. Furthermore, GH(3)-cell exposure to QO-58 effectively increased the amplitude of I(K(Ca)) as well as enhanced the activity of BK(Ca) channels. Under inside-out configuration, QO-58, applied at the cytosolic leaflet of the channel, activated BK(Ca)-channel activity, and its increase could be attenuated by further addition of verruculogen, but not by linopirdine (10 μM). The application of QO-58 could lead to a leftward shift in the activation curve of BK(Ca) channels with neither change in the gating charge nor in single-channel conductance. Moreover, cell exposure of QO-58 (10 μM) resulted in a minor suppression of I(K(erg)) amplitude in response to membrane hyperpolarization. The docking results also revealed that there are possible interactions of the QO-58 molecule with the KCNQ or K(Ca)1.1 channel. Overall, dual activation of I(K(M)) and I(K(Ca)) caused by the presence of QO-58 eventually may have high impacts on the functional activity (e.g., anti-nociceptive effect) residing in electrically excitable cells. Care must be exercised when interpreting data generated with QO-58 as it is not entirely KCNQ/K(V)7 selective.
format Online
Article
Text
id pubmed-9266432
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92664322022-07-09 Evidence for Dual Activation of I(K(M)) and I(K(Ca)) Caused by QO-58 (5-(2,6-Dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1H-pyrazolol[1,5-a]pyrimidin-7-one) Wu, Chao-Liang Fu, Poyuan Cho, Hsin-Yen Chuang, Tzu-Hsien Wu, Sheng-Nan Int J Mol Sci Article QO-58 (5-(2,6-dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1H-pyrazolol[1,5-a]pyrimidin-7-one) has been regarded to be an activator of K(V)7 channels with analgesic properties. However, whether and how the presence of this compound can result in any modifications of other types of membrane ion channels in native cells are not thoroughly investigated. In this study, we investigated its perturbations on M-type K(+) current (I(K(M))), Ca(2+)-activated K(+) current (I(K(Ca))), large-conductance Ca(2+)-activated K(+) (BK(Ca)) channels, and erg-mediated K(+) current (I(K(erg))) identified from pituitary tumor (GH(3)) cells. Addition of QO-58 can increase the amplitude of I(K(M)) and I(K(Ca)) in a concentration-dependent fashion, with effective EC(50) of 3.1 and 4.2 μM, respectively. This compound could shift the activation curve of I(K(M)) toward a leftward direction with being void of changes in the gating charge. The strength in voltage-dependent hysteresis (V(hys)) of I(K(M)) evoked by upright triangular ramp pulse (V(ramp)) was enhanced by adding QO-58. The probabilities of M-type K(+) (K(M)) channels that will be open increased upon the exposure to QO-58, although no modification in single-channel conductance was seen. Furthermore, GH(3)-cell exposure to QO-58 effectively increased the amplitude of I(K(Ca)) as well as enhanced the activity of BK(Ca) channels. Under inside-out configuration, QO-58, applied at the cytosolic leaflet of the channel, activated BK(Ca)-channel activity, and its increase could be attenuated by further addition of verruculogen, but not by linopirdine (10 μM). The application of QO-58 could lead to a leftward shift in the activation curve of BK(Ca) channels with neither change in the gating charge nor in single-channel conductance. Moreover, cell exposure of QO-58 (10 μM) resulted in a minor suppression of I(K(erg)) amplitude in response to membrane hyperpolarization. The docking results also revealed that there are possible interactions of the QO-58 molecule with the KCNQ or K(Ca)1.1 channel. Overall, dual activation of I(K(M)) and I(K(Ca)) caused by the presence of QO-58 eventually may have high impacts on the functional activity (e.g., anti-nociceptive effect) residing in electrically excitable cells. Care must be exercised when interpreting data generated with QO-58 as it is not entirely KCNQ/K(V)7 selective. MDPI 2022-06-24 /pmc/articles/PMC9266432/ /pubmed/35806047 http://dx.doi.org/10.3390/ijms23137042 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wu, Chao-Liang
Fu, Poyuan
Cho, Hsin-Yen
Chuang, Tzu-Hsien
Wu, Sheng-Nan
Evidence for Dual Activation of I(K(M)) and I(K(Ca)) Caused by QO-58 (5-(2,6-Dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1H-pyrazolol[1,5-a]pyrimidin-7-one)
title Evidence for Dual Activation of I(K(M)) and I(K(Ca)) Caused by QO-58 (5-(2,6-Dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1H-pyrazolol[1,5-a]pyrimidin-7-one)
title_full Evidence for Dual Activation of I(K(M)) and I(K(Ca)) Caused by QO-58 (5-(2,6-Dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1H-pyrazolol[1,5-a]pyrimidin-7-one)
title_fullStr Evidence for Dual Activation of I(K(M)) and I(K(Ca)) Caused by QO-58 (5-(2,6-Dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1H-pyrazolol[1,5-a]pyrimidin-7-one)
title_full_unstemmed Evidence for Dual Activation of I(K(M)) and I(K(Ca)) Caused by QO-58 (5-(2,6-Dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1H-pyrazolol[1,5-a]pyrimidin-7-one)
title_short Evidence for Dual Activation of I(K(M)) and I(K(Ca)) Caused by QO-58 (5-(2,6-Dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1H-pyrazolol[1,5-a]pyrimidin-7-one)
title_sort evidence for dual activation of i(k(m)) and i(k(ca)) caused by qo-58 (5-(2,6-dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1h-pyrazolol[1,5-a]pyrimidin-7-one)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266432/
https://www.ncbi.nlm.nih.gov/pubmed/35806047
http://dx.doi.org/10.3390/ijms23137042
work_keys_str_mv AT wuchaoliang evidencefordualactivationofikmandikcacausedbyqo58526dichloro5fluoropyridin3yl3phenyl2trifluoromethyl1hpyrazolol15apyrimidin7one
AT fupoyuan evidencefordualactivationofikmandikcacausedbyqo58526dichloro5fluoropyridin3yl3phenyl2trifluoromethyl1hpyrazolol15apyrimidin7one
AT chohsinyen evidencefordualactivationofikmandikcacausedbyqo58526dichloro5fluoropyridin3yl3phenyl2trifluoromethyl1hpyrazolol15apyrimidin7one
AT chuangtzuhsien evidencefordualactivationofikmandikcacausedbyqo58526dichloro5fluoropyridin3yl3phenyl2trifluoromethyl1hpyrazolol15apyrimidin7one
AT wushengnan evidencefordualactivationofikmandikcacausedbyqo58526dichloro5fluoropyridin3yl3phenyl2trifluoromethyl1hpyrazolol15apyrimidin7one